Guru Ownership Trend
Guru Analysis for Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. (ORMP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $669,285.54.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $68,520 net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 0.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Oramed Pharmaceuticals Inc. (ORMP)
Major holders include Renaissance Technologies (RenTech) ($420,375), Steven Cohen ($72,510). According to the latest reported data, 2 tracked investment managers collectively hold approximately 172,942 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $68,520, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited ORMP. The total reported sell value was $3,990.
Yes, 1 managers opened new positions in ORMP, and 0 increased their existing holdings. The total reported buy value was $72,510.